BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8238787)

  • 1. Is tubular apocrine adenoma a distinct clinical entity?
    Ishiko A; Shimizu H; Inamoto N; Nakmura K
    Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?
    Tellechea O; Reis JP; Marques C; Baptista AP
    Am J Dermatopathol; 1995 Oct; 17(5):499-505. PubMed ID: 8599457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
    Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
    Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocrine type of cutaneous mixed tumor with follicular and sebaceous differentiation.
    Requena L; Sánchez Yus E; Santa Cruz DJ
    Am J Dermatopathol; 1992 Jun; 14(3):186-94. PubMed ID: 1380780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity?
    Fox SB; Cotton DW
    Am J Dermatopathol; 1992 Apr; 14(2):149-54. PubMed ID: 1566975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
    Ansai SI; Anan T; Fukumoto T; Saeki H
    Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringocystadenoma papilliferum: report of the first case on the lower leg.
    Yoshii N; Kanekura T; Setoyama M; Kanzaki T
    J Dermatol; 2004 Nov; 31(11):939-42. PubMed ID: 15729871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
    Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
    Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
    Hsu PJ; Liu CH; Huang CJ
    J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex sweat gland hamartoma: A case report.
    Skopec Z; Berrebi KG; Stone M; Liu V
    J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest.
    Ito K; Ansai SI; Saeki H
    J Nippon Med Sch; 2017; 84(2):79-82. PubMed ID: 28502963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of ductal sweat gland carcinoma connected to syringocystadenoma papilliferum arising in nevus sebaceus.
    Ansai S; Koseki S; Hashimoto H; Hozumi Y; Kondo S
    J Cutan Pathol; 1994 Dec; 21(6):557-63. PubMed ID: 7699123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
    Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
    Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of organoid nevi.
    Coskey RJ
    Cutis; 1982 Mar; 29(3):290-2, 294. PubMed ID: 6279360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevus sebaceous and syringocystadenoma papilliferum.
    Greer KE; Bishop GF; Ober WC
    Arch Dermatol; 1976 Feb; 112(2):206-8. PubMed ID: 183608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Tubular Apocrine Adenoma with Syringocystadenoma Papilliferum that Developed in a Nevus Sebaceus.
    Kim MS; Lee JH; Lee WM; Son SJ
    Ann Dermatol; 2010 Aug; 22(3):319-22. PubMed ID: 20711270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure apocrine nevus. A study of light-microscopic and immunohistochemical features of a rare tumor.
    Ando K; Hashikawa Y; Nakashima M; Nakayama A; Ohashi M
    Am J Dermatopathol; 1991 Feb; 13(1):71-6. PubMed ID: 2003651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.